My research interests are prediction of type 1 diabetes through genetic and islet autoantibody markers. Currently my research focuses on a group of individuals with high risk of type 1 diabetes, based on presence of multiple islet autoantibodies, who have remained free from diabetes or progressed slowly to disease. These rare individuals may help inform strategies to delay or prevent progression to diabetes in other 'at risk' individuals.